Collidion
Petaluma, US · Founded 2015 · Nevada corporation
Find your way into Collidion
Sign up to see every warm intro you have to Collidion
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Collidion team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Collidion is a healthcare holding company that develops, acquires, and licenses novel assets in healthcare, supporting program-focused subsidiaries with capital, operational support, and IP. Its subsidiaries include Spectrum Antimicrobials, which develops anti-infective, disinfection, and sterilization technologies, and Plex Pharmaceuticals, which targets complex diseases such as Parkinson's, glioblastoma, and cataracts.
Founders & leadership
Collidion was founded in 2015 by Hojabr Alimi.
Reported raises · per SEC filings
Form D private placements$14.5M disclosed across 2 rounds · 2016–2019
▶$14.3MraisedOct 2019 · 147 investors · PharmaceuticalsRule 506(c)
- Hojabr AlimiExecutive Officer, Director
- Sameer HarishExecutive Officer
- Gregg AltonDirector
- Ettore M. CarinoDirector
- William H. WatsonExecutive Officer
- Gregory FrenchDirector
- Jeffrey CastilloDirector
- Offering amount
- $15M
- Amount sold
- $14.3M
- Minimum investment
- $10K
- Sales commissions
- $147.2K
- Proceeds to insiders
- $1.5M
- Placement agents
- R.F. Lafferty & Co., Inc.
- First sale
- Feb 2016
- Incorporated
- Corporation, Nevada, 2015
- Federal exemptions
- 06c
▶$275KraisedAug 2019 · 3 investors · PharmaceuticalsRule 506(c)
- Hojabr AlimiExecutive Officer, Director
- Sameer HarishExecutive Officer
- Gregg AltonDirector
- Ettore M. CarinoDirector
- William H. WatsonExecutive Officer
- Gregory FrenchDirector
- Jeffrey CastilloDirector
- Offering amount
- $500K
- Amount sold
- $275K
- Minimum investment
- $50K
- First sale
- Apr 2019
- Incorporated
- Corporation, Nevada, 2015
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Collidion do?
- Collidion is a healthcare holding company that develops, acquires, and licenses novel assets in healthcare, supporting program-focused subsidiaries with capital, operational support, and IP. Its subsidiaries include Spectrum Antimicrobials, which develops anti-infective, disinfection, and sterilization technologies, and Plex Pharmaceuticals, which targets complex diseases such as Parkinson's, glioblastoma, and cataracts.
- Who founded Collidion?
- Collidion was founded by Hojabr Alimi in 2015.
- How much funding has Collidion raised?
- Collidion has disclosed $14.5M raised across 2 rounds.
- Where is Collidion headquartered?
- Collidion is headquartered in Petaluma, US.